BSGM BioSig Technologies Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: BSGM

Price (delayed)

$1.32

Market cap

$14.78M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.95

Enterprise value

$15.04M

BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals (www.biosig.com).

Highlights
BSGM's debt is down by 41% YoY and by 15% from the previous quarter
BioSig Technologies's EPS has increased by 38% YoY and by 16% QoQ
The net income has decreased by 7% YoY but it has increased by 3% QoQ
The equity has dropped by 160% since the previous quarter
BSGM's revenue has shrunk by 94% YoY and by 87% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.biosig.com
Peers: KEN

Key stats

What are the main financial stats of BSGM
Market
Shares outstanding
11.2M
Market cap
$14.78M
Enterprise value
$15.04M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
539.13
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
835.76
Earnings
Revenue
$18,000
EBIT
-$29.04M
EBITDA
-$28.39M
Free cash flow
-$17.5M
Per share
EPS
-$3.95
Free cash flow per share
-$2.38
Book value per share
-$0.34
Revenue per share
$0
TBVPS
$0.21
Balance sheet
Total assets
$1.8M
Total liabilities
$4.69M
Debt
$452,000
Equity
-$3.02M
Working capital
-$4.05M
Liquidity
Debt to equity
-0.15
Current ratio
0.12
Quick ratio
0.07
Net debt/EBITDA
-0.01
Margins
EBITDA margin
-157,705.6%
Gross margin
100%
Net margin
-161,338.9%
Operating margin
-158,400%
Efficiency
Return on assets
-818.4%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
-161,338.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BSGM stock price

How has the BioSig Technologies stock price performed over time
Intraday
-10.81%
1 week
-19.02%
1 month
144.9%
1 year
-4.35%
YTD
177.89%
QTD
99.7%

Financial performance

How have BioSig Technologies's revenue and profit performed over time
Revenue
$18,000
Gross profit
$18,000
Operating income
-$28.51M
Net income
-$29.04M
Gross margin
100%
Net margin
-161,338.9%
BSGM's revenue has shrunk by 94% YoY and by 87% QoQ
BioSig Technologies's gross profit has shrunk by 92% YoY and by 84% QoQ
BioSig Technologies's gross margin has increased by 25% YoY and by 24% QoQ
The net income has decreased by 7% YoY but it has increased by 3% QoQ

Growth

What is BioSig Technologies's growth rate over time

Valuation

What is BioSig Technologies stock price valuation
P/E
N/A
P/B
N/A
P/S
539.13
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
835.76
BioSig Technologies's EPS has increased by 38% YoY and by 16% QoQ
The equity has dropped by 160% since the previous quarter
BSGM's revenue has shrunk by 94% YoY and by 87% QoQ
The stock's price to sales (P/S) is 22% less than its last 4 quarters average of 692.1

Efficiency

How efficient is BioSig Technologies business performance
BioSig Technologies's return on assets has shrunk by 134% YoY and by 12% QoQ

Dividends

What is BSGM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BSGM.

Financial health

How did BioSig Technologies financials performed over time
BioSig Technologies's total assets is 62% less than its total liabilities
The current ratio has dropped by 66% year-on-year and by 56% since the previous quarter
BioSig Technologies's total assets has plunged by 56% YoY and by 43% from the previous quarter
BSGM's debt is 115% more than its equity
The equity has dropped by 160% since the previous quarter
BSGM's debt to equity has plunged by 106% YoY but it has soared by 67% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.